Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol.

Authors:
Address: Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada T6G 2N8.
Journal:

Publication:

abstract

dioxins are widespread environmental contaminants that induce the carcinogen-activating enzyme, cytochrome P450 1A1 (CYP1A1) through an aryl hydrocarbon receptor (AhR)-dependent mechanism. We previously demonstrated that harmine inhibits the dioxin-mediated induction of Cyp1a1 activity in murine hepatoma cells. Therefore, the aim of this study is to determine the effect of harmine and its main metabolite, harmol, on the dioxin-mediated induction of CYP1A1 in human HepG2 and murine Hepa 1c1c7 hepatoma cells. Our results showed that harmine and harmol significantly inhibited the dioxin-mediated induction of CYP1A1 at mRNA, protein, and activity levels in a concentration-dependent manner in human and murine hepatoma cells. Moreover, harmine and harmol inhibited the AhR-dependent luciferase activity and the activation and transformation of AhR using the electrophoretic mobility shift assay. In addition, harmine and harmol displaced [(3)H]TCDD in the competitive ligand binding assay. At posttranslational level, both harmine and harmol decreased the protein stability of CYP1A1, suggesting that posttranslational mechanism is involved. Furthermore, we demonstrated that the underlying mechanisms of the posttranslational modifications of both compounds involve ubiquitin-proteasomal pathway and direct inhibitory effects of CYP1A1 enzyme. We concluded that harmine and its metabolite, harmol, are new inhibitors of dioxin-mediated effects.

Related Articles
Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms.
Food Chem Toxicol. 2012
Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms.
El Gendy MA, Soshilov AA, Denison MS, El-Kadi AO. Food Chem Toxicol. 2012 Feb; 50(2):353-62. Epub 2011 Oct 21.
Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanism.
Toxicol Appl Pharmacol. 2010
Harman induces CYP1A1 enzyme through an aryl hydrocarbon receptor mechanism.
El Gendy MA, El-Kadi AO. Toxicol Appl Pharmacol. 2010 Nov 15; 249(1):55-64. Epub 2010 Aug 20.
Mercury modulates the CYP1A1 at transcriptional and posttranslational levels in human hepatoma HepG2 cells.
Toxicol Lett. 2010
Mercury modulates the CYP1A1 at transcriptional and posttranslational levels in human hepatoma HepG2 cells.
Amara IE, Anwar-Mohamed A, El-Kadi AO. Toxicol Lett. 2010 Dec 15; 199(3):225-33. Epub 2010 Sep 15.
Transcriptional and posttranscriptional regulation of CYP1A1 by vanadium in human hepatoma HepG2 cells.
Cell Biol Toxicol. 2010
Transcriptional and posttranscriptional regulation of CYP1A1 by vanadium in human hepatoma HepG2 cells.
Abdelhamid G, Anwar-Mohamed A, Badary OA, Moustafa AA, El-Kadi AO. Cell Biol Toxicol. 2010 Oct; 26(5):421-34. Epub 2010 Mar 11.
Transcriptional and posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by lead in HepG2 cells: a role of heme oxygenase.
Toxicology. 2012
Transcriptional and posttranslational mechanisms modulating the expression of the cytochrome P450 1A1 gene by lead in HepG2 cells: a role of heme oxygenase.
Korashy HM, El-Kadi AO. Toxicology. 2012 Jan 27; 291(1-3):113-21. Epub 2011 Nov 22.
Camel Milk Modulates the Expression of Aryl Hydrocarbon Receptor-Regulated Genes, Cyp1a1, Nqo1, and Gsta1, in Murine hepatoma Hepa 1c1c7 Cells.
J Biomed Biotechnol. 2012
Camel Milk Modulates the Expression of Aryl Hydrocarbon Receptor-Regulated Genes, Cyp1a1, Nqo1, and Gsta1, in Murine hepatoma Hepa 1c1c7 Cells.
Korashy HM, El Gendy MA, Alhaider AA, El-Kadi AO. J Biomed Biotechnol. 2012; 2012:782642. Epub 2012 Feb 27.

To top • Home

TraveldoctorOnline 2001 • Disclaimer • webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.